COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A ‘two-for’ option

Moderna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3 clinical trials, mRNA-1083 achieved a better immune response than other vaccines.Moderna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3 clinical trials, mRNA-1083 achieved a better immune response than other vaccines.Read More4e72b81d-85c7-523e-a399-5d707a934068, fox-news/health, fox-news/health/infectious-disease/vaccines, fox-news/health/infectious-disease/coronavirus, fox-news/health/respiratory-health/cold-and-flu, fox-news/health/infectious-disease, fox-news/lifestyle, fox-news/health/medical-research, fox-news/health/respiratory-health, fnc, fox-news/health, article, Fox News, Melissa RudyFOX News : Health